发明名称 ANTIOXIDANT ENHANCEMENT OF THERAPY FOR HYPERPROLIFERATIVE CONDITIONS
摘要 A method to enhance the cytotoxic activity of an antineoplastic drug comprising administering an effective amount of the antineoplastic drug to a host exhibiting abnormal cell proliferation in combination with an effective cytotoxicity-increasing amount of an antioxidant. The invention also includes a method to decrease the toxicity to an antineoplast ic agent or increase the therapeutic index of an antineoplastic agent administered for the treatment of a solid growth of abnormally proliferating cells, comprising administering an antioxidant prior to, with, or following the antineoplastic treatment.
申请公布号 CA2294247(C) 申请公布日期 2004.10.26
申请号 CA19982294247 申请日期 1998.07.01
申请人 ATHEROGENICS, INC. 发明人 BEAUCHAMP, R. DANIEL;MEDFORD, RUSSELL M.;COFFEY, ROBERT J.;CHINERY, REBECCA;WADZINSKI, BRIAN
分类号 A61K47/20;A61K31/00;A61K31/138;A61K31/198;A61K31/336;A61K31/337;A61K31/34;A61K31/357;A61K31/365;A61K31/381;A61K31/395;A61K31/396;A61K31/40;A61K31/407;A61K31/409;A61K31/416;A61K31/4164;A61K31/4166;A61K31/4168;A61K31/4178;A61K31/4188;A61K31/4196;A61K31/4353;A61K31/437;A61K31/4375;A61K31/4468;A61K31/451;A61K31/47;A61K31/4704;A61K31/473;A61K31/495;A61K31/5025;A61K31/506;A61K31/513;A61K31/519;A61K31/52;A61K31/53;A61K31/566;A61K31/585;A61K31/67;A61K31/675;A61K31/70;A61K31/7008;A61K31/704;A61K31/7042;A61K31/706;A61K31/7064;A61K31/7072;A61K31/7076;A61K31/7135;A61K38/43;A61K38/45;A61K38/55;A61K45/00;A61K45/06;A61P9/00;A61P17/06;A61P35/00;A61P43/00;(IPC1-7):A61K31/00 主分类号 A61K47/20
代理机构 代理人
主权项
地址